Novel imaging techniques in refractory pituitary adenomas

[1]  Xiaozhu Lin,et al.  DRD2 expression based on ^18F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study , 2023, Endocrine.

[2]  T. Wan,et al.  A Preoperative MRI-Based Radiomics-Clinicopathological Classifier to Predict the Recurrence of Pituitary Macroadenoma Within 5 Years , 2022, Frontiers in Neurology.

[3]  M. Berker,et al.  68Ga-DOTATATE PET/CT in Pituitary Carcinoma. , 2021, Clinical Nuclear Medicine.

[4]  A. Kolias,et al.  Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas. , 2021, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Chunlong Zhong,et al.  Invasive Corridor of Clivus Extension in Pituitary Adenoma: Bony Anatomic Consideration, Surgical Outcome and Technical Nuances , 2021, Frontiers in Oncology.

[6]  O. Alonso,et al.  18F-fallypride and 11C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series , 2021, World journal of nuclear medicine.

[7]  S. Melmed.  Pituitary-Tumor Endocrinopathies. , 2020, The New England journal of medicine.

[8]  Liangyin Chen,et al.  A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. , 2020, European journal of radiology.

[9]  P. Recinos,et al.  Superiority of constructive interference in steady-state MRI sequencing over T1-weighted MRI sequencing for evaluating cavernous sinus invasion by pituitary macroadenomas. , 2019, Journal of neurosurgery.

[10]  T. Santarius,et al.  Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI. , 2016, European journal of endocrinology.

[11]  E. Knosp,et al.  Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. , 2015, Journal of neurosurgery.

[12]  Y. Korogi,et al.  Delineation of optic nerves and chiasm in close proximity to large suprasellar tumors with contrast-enhanced FIESTA MR imaging. , 2012, Radiology.

[13]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  O. Dekkers,et al.  European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. , 2018, European journal of endocrinology.

[15]  J. Bonneville.  Magnetic Resonance Imaging of Pituitary Tumors. , 2016, Frontiers of hormone research.

[16]  J. Pickard,et al.  A role for 11 C-methionine PET imaging in ACTH-dependent Cushing’s syndrome , 2015 .

[17]  L. Lenchik.  Functional imaging , 2007, Annals of Biomedical Engineering.